Evidence for a common biological basis of the absorption trait, hallucinogen effects, and positive symptoms: Epistasis between 5-HT2a and COMT polymorphisms
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Absorption represents a disposition to experience altered states of consciousness characterized by intensively focused attention. It is correlated with hypnotic susceptibility and includes phenomena ranging from vivid perceptions and imaginations to mystical experiences. Based on the assumption that drug-induced and naturally occurring mystical experiences share common neural mechanisms, we hypothesized that Absorption is influenced by the T102C polymorphism affecting the 5-HT2a receptor, which is known to be an important target site of hallucinogens like LSD. Based on the pivotal role ascribed to the prefrontal executive control network for absorbed attention and positive symptoms in schizophrenia, it was further hypothesized that Absorption is associated with the VAL158MET polymorphism of the catechol-O-methyltransferase (COMT) gene affecting the dopaminergic neurotransmitter system. The Tellegen Absorption Scale was administered to 336 subjects (95 male, 241 female). Statistical analysis revealed that the group with the T/T genotype of the T102C polymorphism, implying a stronger binding potential of the 5-HT2a receptor, indeed had significantly higher Absorption scores (F = 10.00, P = 0.002), while no main effect was found for the COMT polymorphism. However, the interaction between T102C and COMT genotypes yielded significance (F = 3.89; P = 0.049), underlining the known functional interaction between the 5-HT and the dopaminergic system. These findings point to biological foundations of the personality trait of Absorption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tellegen, A., & Atkinson, G. (1974) · Journal of Abnormal Psychology · doi:10.1037/h0036681 · Cited by 2,196
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018 · cited 2×
“Yet, a study on the influence of the DA-antagonist haloperidol on psychological effects of the hallucinogen psilocybin [Vollenweider et al., 1998] found that only some effects were reduced (derealization and depersonalization), while others were left unchanged (illusions, pseudo-hallucinations, synesthetic phenomena)…”
BackgroundMapping the genetic variation of executive attention onto brain activity
Fan, J., Fossella, J., Sommer, T., Wu, Y., & Posner, M. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0732088100 · Cited by 464
Assessing the molecular genetics of attention networks
Fossella, J., Sommer, T., Fan, J., Wu, Y., Swanson, J. M., Pfaff, D. W., & Posner, M. I. (2002) · BMC Neuroscience · doi:10.1186/1471-2202-3-14 · Cited by 339 · cited 2×
“, 2003], also superior performance of executive attention was found to be associated with the VAL/VAL genotype in healthy subjects [Fossella et al., 2002].”
BackgroundHypnosis Modulates Activity in Brain Structures Involved in the Regulation of Consciousness
Rainville, P., Hofbauer, R. K., Bushnell, M. C., Duncan, G. H., & Price, D. D. (2002) · Journal of Cognitive Neuroscience · doi:10.1162/089892902760191117 · Cited by 335
Hypnosis and Neuroscience: A Cross Talk Between Clinical and Cognitive Research
Raz, A., & Shapiro, T. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.1.85 · Cited by 105 · cited 1×
“The ACC is the key structure of the executive control network and a target area of the dopaminergic (DA) system [Raz and Shapiro, 2002].”
Background
Cited by
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
“, 2012), and (2) be associated with a polymorphism linked to stronger 5-HT2AR binding (Ott et al., 2005).”
BackgroundInfluentialPredicting responses to psychedelics: a prospective study
Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R. E., Hampshire, A. D. G., Lorenz, R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00897 · Cited by 417
Prediction of Psilocybin Response in Healthy Volunteers
Studerus, E., Gamma, A., Kometer, M., & Vollenweider, F. X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030800 · Cited by 369
The molecular genetic architecture of human personality: beyond self-report questionnaires
Ebstein, R. P. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001814 · Cited by 366
LSD enhances suggestibility in healthy volunteers
Carhart-Harris, R. L., Kaelen, M., Whalley, M. G., Bolstridge, M., Feilding, A., & Nutt, D. J. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3714-z · Cited by 320
“1999), is associated with elevated trait absorption (Ott et al. 2005).”
BackgroundThe paradoxical psychological effects of lysergic acid diethylamide LSD
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., Feilding, A., & Nutt, D. J. (2016) · Psychological Medicine · doi:10.1017/s0033291715002901 · Cited by 293
Hallucinations: The science of idiosyncratic perception.
Aleman, A., & Larøi, F. (2008) · American Psychological Association eBooks · doi:10.1037/11751-000 · Cited by 285
Phenomenology, Structure, and Dynamic of Psychedelic States
Preller, K. H., & Vollenweider, F. X. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_459 · Cited by 282
A systematic study of microdosing psychedelics
Polito, V., & Stevenson, R. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211023 · Cited by 235
Aday, J. S., Davis, A. K., Mitzkovitz, C. M., Bloesch, E. K., & Davoli, C. C. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00014 · Cited by 224
Absorption and spiritual experience: a review of evidence and potential mechanisms
Lifshitz, M., van Elk, M., & Luhrmann, T. M. (2019) · Consciousness and Cognition · doi:10.1016/j.concog.2019.05.008 · Cited by 160
Taves, A. (2020) · Perspectives on Psychological Science · doi:10.1177/1745691619895047 · Cited by 140
Serotonergic psychedelics and personality: A systematic review of contemporary research
Bouso, J. C., dos Santos, R. G., Alcázar-Córcoles, M. Á., & Hallak, J. E. C. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.004 · Cited by 134
Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression
Szigeti, B., Weiss, B., Rosas, F. E., Erritzoe, D., Nutt, D., & Carhart-Harris, R. (2024) · Psychological Medicine · doi:10.1017/s0033291723003653 · Cited by 89
Dream-enacting behaviors in a normal population
Nielsen, T., Svob, C., & Kuiken, D. (2009) · SLEEP · doi:10.1093/sleep/32.12.1629 · Cited by 62
Rominger, C., Weiss, E. M., Nagl, S., Niederstätter, H., Parson, W., & Papousek, I. (2014) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207144.2014.931177 · Cited by 31
Hypnotizability and Catechol-O-Methyltransferase (COMT) polymorphysms in Italians
Presciuttini, S., Gialluisi, A., Barbuti, S., Curcio, M., Scatena, F., Carli, G., & Santarcangelo, E. L. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00929 · Cited by 30
Tolerability, assessment, and prediction of psilocybin-induced altered states of consciousness
Studerus, E. (2012) · University of Zurich · doi:10.5167/uzh-164092 · Cited by 6
Metadata
- Authors
- Ott, U., Reuter, M., Hennig, J., & Vaitl, D.
- Venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Publisher
- Wiley
- Published
- 2005-08-05
- Volume
- 137B
- Issue
- 1
- Pages
- 29-32
- ISSN
- 1552-4841 (ISSN-L)
- 1552-485X
- OpenAlex
- W2066323805
- Cited by
- 95
- References
- 8
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.